Zepbound: tirzepatide approved for weight management
Zepbound is the brand name for injectable tirzepatide manufactured by Eli Lilly, FDA-approved for chronic weight management. It acts on two receptors: GIP and GLP-1.
Brand notice: NoGuiltMeds is not affiliated with the manufacturers of these medications. Trademarks mentioned belong to their respective owners. Compounded products are not equivalent to FDA-approved brand-name products.
Frequently asked questions
What is the difference between Zepbound and Mounjaro?
Both contain tirzepatide. Zepbound is approved for weight management, while Mounjaro is approved for type 2 diabetes.
Is Zepbound better than Wegovy?
They are different medications with distinct mechanisms. The provider determines which is most appropriate based on each clinical case.
Does NoGuiltMeds sell Zepbound?
No. NoGuiltMeds offers evaluation for compounded tirzepatide, formulated by licensed pharmacies. We do not distribute Zepbound.
You might also like
Online medical evaluation
Ready to start? The evaluation is free.
A licensed provider reviews every case. If you qualify, your plan can start from $99.
Start evaluation